Open access · OA
via Europe PMC
Sarcopenia and Vitamin B12: Where Do We Stand?
Mavrou K, Ntelis N, Karakousis ND, Papagianni M.
Muscles (Basel, Switzerland) · 2026
Abstract
<b>Background/Objectives:</b> Sarcopenia is an age-related skeletal muscle disorder associated with functional decline, frailty, and reduced quality of life. Vitamin B12 plays an essential role in neuromuscular function, DNA synthesis, and homocysteine metabolism, yet its relationship with sarcopenia remains incompletely understood. This narrative review aimed to summarize the current evidence regarding the association between vitamin B12 status and sarcopenia and to discuss the potential biological mechanisms underlying this relationship. <b>Methods:</b> A literature search was conducted in PubMed, Scopus, and Web of Science to identify relevant studies published up to 4 September 2026. Twenty studies met the eligibility criteria and were included in this narrative review. Evidence regarding muscle mass, muscle strength, physical performance, and the biological mechanisms linking vitamin B12 to sarcopenia was synthesized narratively. <b>Results:</b> The included studies reported heterogeneous findings regarding the association between vitamin B12 status and sarcopenia-related outcomes. Some studies suggested that adequate vitamin B12 status was associated with better muscle mass and physical performance, whereas others found no independent association after adjustment for potential confounding factors. Vitamin B12 deficiency has been linked to neuromuscular dysfunction, hyperhomocysteinemia, and impaired muscle metabolism, providing biological plausibility for a potential association. However, findings regarding muscle strength and the overall association with sarcopenia remained inconsistent across studies, reflecting differences in study populations, diagnostic criteria, and methodological approaches. <b>Conclusions:</b> Current evidence suggests heterogeneous and, in some cases, subgroup-specific associations between vitamin B12-related measures and selected sarcopenia-related outcomes. However, methodological heterogeneity, the predominantly observational nature of the evidence, and potential residual confounding preclude causal inferences and do not allow a reliable determination of which individual components of sarcopenia are most consistently associated with vitamin B12.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/muscles5040069
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
K, M., N, N., ND, K., & M., P. (2026). Sarcopenia and Vitamin B12: Where Do We Stand?. <em>Muscles (Basel, Switzerland)</em>. https://doi.org/10.3390/muscles5040069
Vancouver
K M, N N, ND K, M. P. Sarcopenia and Vitamin B12: Where Do We Stand?. Muscles (Basel, Switzerland). 2026. doi:10.3390/muscles5040069.
BibTeX
@article{mavrou2026Sarcop,
title = {Sarcopenia and Vitamin B12: Where Do We Stand?},
author = {Mavrou K and Ntelis N and Karakousis ND and Papagianni M.},
journal = {Muscles (Basel, Switzerland)},
year = {2026},
doi = {10.3390/muscles5040069},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC geriatrics 2026
Open access · OA
What is the impact of CRP, hs-CRP, IL-6, IL-10, and TNFα in physical performance in community-dwelling older adults: a systematic review.
Biomedicines 2026
Open access · OA
The Gut-Muscle Axis in Sarcopenia: Mechanisms, Evidence Gaps and Translational Challenges.
BMC Geriatrics 2026
Open access · CC-BY
What is the impact of CRP, hs-CRP, IL-6, IL-10, and TNFα in physical performance in community-dwelling older adults: a systematic review
Journal of Cosmetic Dermatology 2025
Open access · CC-BY
Advances in Longevity: The Intersection of Regenerative Medicine and Cosmetic Dermatology
Trakya University 2021
Open access · US-GOV
Determination of Sarcopenia Risk and Related Factors in Pediatric Oncological Patients
Scientific reports 2026
Citation only